TNF-α inhibitors are used to treat various inflammatory and autoimmune diseases, including HS (5), but in rare cases, adalimumab has been associated with paradoxical inflammatory adverse events (PAEs), such as posterior uveitis (2). This evidence concerns the gene TNF and autoimmune disease.